SCHEMBL955013

SCHEMBL955013

[O-][N+]12C=CN=CC1=CN=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337391 0.47
Iodide SCHEMBL818987 0.42
Hydrochloric Acid SCHEMBL4832902 0.36
Bromide SCHEMBL21804716 0.36
SCHEMBL30131001 0.29
SCHEMBL147876 0.28
SCHEMBL13719381 0.26
Potassium Ion SCHEMBL23113871 0.24
SCHEMBL11567446 0.21
SCHEMBL4093276 0.21

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9993477-B2 Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors H. LUNDBECK A/S (DK) 2018-06-12 US disclosed
US-20170173018-A1 SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS PDE9 INHIBITORS SUNDIA MEDITECH COMPANY, LTD. (CN) 2017-06-22 US disclosed
US-9643970-B2 Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors H. LUNDBECK A/S (DK) 2017-05-09 US disclosed
US-7872124-B2 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-18 US disclosed